BC
CVS icon

Barnett & Company’s CVS Health CVS Stock Holding History

Barnett & Company’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,590
Closed -$1.23M – 81
2024
Q3 		$1.23M Sell
19,590
-19,415
-50% -$1.13M 0.81% 38
2024
Q2 		$2.3M Sell
39,005
-1,494
-4% -$93.5K 1.65% 22
2024
Q1 		$3.23M Sell
40,499
-1,350
-3% -$103K 2.21% 13
2023
Q4 		$3.3M Sell
41,849
-100
-0.2% -$7.12K 2.48% 11
2023
Q3 		$2.93M Sell
41,949
-8,626
-17% -$611K 2.29% 14
2023
Q2 		$3.5M Sell
50,575
-805
-2% -$57.3K 2.6% 11
2023
Q1 		$3.82M Buy
51,380
+1,711
+3% +$143K 2.9% 12
2022
Q4 		$4.63M Sell
49,669
-1,039
-2% -$100K 3.54% 10
2022
Q3 		$4.84M Sell
50,708
-1,714
-3% -$170K 4.27% 4
2022
Q2 		$4.86M Hold
52,422
– – 3.88% 6
2022
Q1 		$5.31M Sell
52,422
-30
-0.1% -$3.15K 3.77% 5
2021
Q4 		$5.41M Buy
52,452
+445
+0.9% +$41.1K 3.77% 3
2021
Q3 		$4.41M Sell
52,007
-5,558
-10% -$466K 3.32% 6
2021
Q2 		$4.8M Sell
57,565
-4,808
-8% -$394K 3.17% 5
2021
Q1 		$4.69M Sell
62,373
-343
-0.5% -$25K 2.5% 11
2020
Q4 		$4.28M Sell
62,716
-2,743
-4% -$178K 2.69% 10
2020
Q3 		$3.82M Buy
65,459
+3,455
+6% +$215K 2.73% 9
2020
Q2 		$4.03M Sell
62,004
-4,159
-6% -$262K 3.27% 7
2020
Q1 		$3.92M Sell
66,163
-3,700
-5% -$247K 3.78% 7
2019
Q4 		$5.19M Sell
69,863
-9,821
-12% -$690K 3.16% 8
2019
Q3 		$5.03M Buy
79,684
+2,300
+3% +$136K 2.94% 7
2019
Q2 		$4.22M Buy
77,384
+2,880
+4% +$155K 2.38% 10
2019
Q1 		$4.02M Sell
74,504
-2,290
-3% -$141K 2.29% 12
2018
Q4 		$5.03M Sell
76,794
-2,695
-3% -$201K 2.88% 8
2018
Q3 		$6.26M Buy
79,489
+1,979
+3% +$141K 2.85% 7
2018
Q2 		$4.99M Buy
77,510
+7,558
+11% +$498K 2.42% 8
2018
Q1 		$4.35M Buy
69,952
+575
+0.8% +$41.3K 2.23% 9
2017
Q4 		$5.03M Buy
69,377
+375
+0.5% +$27.3K 2.46% 7
2017
Q3 		$5.61M Sell
69,002
-5,100
-7% -$403K 2.84% 2
2017
Q2 		$5.96M Buy
74,102
+425
+0.6% +$33.6K 2.84% 2
2017
Q1 		$5.78M Sell
73,677
-100
-0.1% -$7.98K 3.17% 2
2016
Q4 		$5.82M Sell
73,777
-30
-0% -$2.43K 3.04% 2
2016
Q3 		$6.57M Buy
73,807
+463
+0.6% +$43.7K 3.54% 2
2016
Q2 		$7.02M Sell
73,344
-2,105
-3% -$210K 3.9% 1
2016
Q1 		$7.83M Sell
75,449
-3,033
-4% -$295K 4.12% 1
2015
Q4 		$7.67M Buy
78,482
+297
+0.4% +$29.1K 4.04% 2
2015
Q3 		$7.54M Sell
78,185
-1,250
-2% -$131K 3.66% 2
2015
Q2 		$8.33M Sell
79,435
-657
-0.8% -$67.1K 3.43% 1
2015
Q1 		$8.27M Sell
80,092
-470
-0.6% -$47.6K 3.25% 2
2014
Q4 		$7.76M Sell
80,562
-570
-0.7% -$50.2K 2.99% 2
2014
Q3 		$6.46M Sell
81,132
-525
-0.6% -$41.4K 2.59% 2
2014
Q2 		$6.15M Sell
81,657
-1,288
-2% -$97.3K 2.59% 1
2014
Q1 		$6.21M Buy
82,945
+775
+0.9% +$54.7K 2.78% 1
2013
Q4 		$5.88M Buy
82,170
+658
+0.8% +$42.3K 2.74% 1
2013
Q3 		$4.63M Buy
81,512
+6,515
+9% +$388K 2.38% 2
2013
Q2 		$4.29M Buy
+74,997
New +$4.35M 2.35% 2

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Barnett & Company's CVS Position: Q4 2024 in Review

Barnett & Company sold out of CVS Health (CVS) in Q4 2024, closing a stake of 19,590 shares — an estimated $1.23M sold.

Barnett & Company first reported a position in CVS in Q2 2013 and held it in 46 quarters. The position peaked at $8.33M in Q2 2015. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Barnett & Company reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Barnett & Company sold 19,590 CVS Health shares in Q4 2024, an estimated $1.23M.
  • Barnett & Company first reported a position in CVS Health in Q2 2013 and held it in 46 quarters.
  • Barnett & Company's CVS Health position peaked at $8.33M in Q2 2015.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Barnett & Company's 13F filing for Q4 2024, filed 11 Feb 2025.